Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 277

Showing 1-25 of 277 citing articles:

The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018
Keke Dang, Xuanyang Wang, Jinxia Hu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 178
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 115
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 96
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 797-809
Closed Access | Times Cited: 86
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
Do Young Kim
Journal of Liver Cancer (2024) Vol. 24, Iss. 1, pp. 622-70
Open Access | Times Cited: 48
Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma
Yutong Chen, Weiran Huang, Jian Ouyang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2862-2862
Open Access | Times Cited: 47
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.
Biology (2023) Vol. 12, Iss. 7, pp. 984-984
Open Access | Times Cited: 46
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019
Xiaoning Wu, Feng Xue, Nan Zhang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 45
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 43
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography
Giovanna Ferraioli, R. Graham Barr, Annalisa Berzigotti, et al.
Ultrasound in Medicine & Biology (2024) Vol. 50, Iss. 8, pp. 1071-1087
Closed Access | Times Cited: 33
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 31
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 29
Development of Polymethine Dyes for NIR‐II Fluorescence Imaging and Therapy
Xin Chen, Jieyan Li, Shubham Roy, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 23
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 17
Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma
Rebecca Wenling Zeng, Christen En Ya Ong, Elden Yen Hng Ong, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 12, pp. 2394-2402.e15
Closed Access | Times Cited: 17
Ketocyanine‐Based Fluorescent Probe Revealing the Polarity Heterogeneity of Lipid Droplets and Enabling Accurate Diagnosis of Hepatocellular Carcinoma
Deming He, Minmin Yan, Qiuling Sun, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 7
Closed Access | Times Cited: 16
Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
Pojsakorn Danpanichkul, Vincent Chen, Nathorn Chaiyakunapruk, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 340-349
Closed Access | Times Cited: 16
Autophagy, Oxidative Stress, and Alcoholic Liver Disease: A Systematic Review and Potential Clinical Applications
Daniel Salete-Granado, Cristina Carbonell, David Puertas-Miranda, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 33
Fecal Microbiota Transplantation in Liver Cirrhosis
Adrian Boicean, Victoria Bîrluțiu, Cristian Ichim, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2930-2930
Open Access | Times Cited: 29
MAFLD: an optimal framework for understanding liver cancer phenotypes
Harry Crane, Cameron Gofton, Ankur Sharma, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 947-964
Open Access | Times Cited: 27
Alcohol and the mechanisms of liver disease
Mo Chen, Wanglei Zhong, Weiqi Xu
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 8, pp. 1233-1240
Open Access | Times Cited: 24
Alcohol-associated liver disease: Epidemiology and management
Helena Hernández-Évole, Natalia Jiménez, Elisa Pose, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 1, pp. 101162-101162
Open Access | Times Cited: 24
Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044
Yang Liu, Zhouyi Sun, Qianwen Wang, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 1028-1044
Open Access | Times Cited: 23
Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study
Anna Emilie Kann, Peter Jepsen, Lone Galmstrup Madsen, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 11, pp. 1028-1034
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top